Global Pneumococcal Vaccines Market Report 2022: Featuring Pfizer, Merck & Co, & GlaxoSmithKline
24. Oktober 2022 06:13 ET
|
Research and Markets
Dublin, Oct. 24, 2022 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market, by Vaccine Type, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030"...
Global Pneumococcal Vaccines Disease Analysis Report 202: Overall Likelihood of Approval of a Phase I Pneumococcal Vaccine is 16.7%
09. April 2021 06:48 ET
|
Research and Markets
Dublin, April 09, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Pneumococcal Vaccines" report has been added to ResearchAndMarkets.com's offering. The value of the pneumococcal vaccines market...
Pneumococcal Vaccines Market, 2024 - Prevnar 13 / Pneumovax 23 / V114 / PF-06482077
16. Oktober 2020 05:38 ET
|
Research and Markets
Dublin, Oct. 16, 2020 (GLOBE NEWSWIRE) -- The "Pneumococcal Vaccines Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering. The value of the pneumococcal...